within Pharmacolibrary.Drugs.ATC.S;

model S01AE03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 1,
    Cl             = 34.6 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 400 / 1000000,
    adminCount     = 1,
    Vd             = 0.103,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.016666666666666666,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Ciprofloxacin is a broad-spectrum fluoroquinolone antibiotic used to treat a variety of bacterial infections, including urinary tract infections, respiratory tract infections, and eye infections. It is approved for both systemic and ophthalmic uses in many countries.</p><h4>Pharmacokinetics</h4><p>Two-compartment model in healthy adult volunteers after intravenous administration.</p><h4>References</h4><ol><li><p>van Rhee, KP, et al., &amp; Knibbe, CAJ (2022). Ciprofloxacin Pharmacokinetics After Oral and Intravenous Administration in (Morbidly) Obese and Non-obese Individuals: A Prospective Clinical Study. <i>Clinical pharmacokinetics</i> 61(8) 1167–1175. DOI:<a href=&quot;https://doi.org/10.1007/s40262-022-01130-5&quot;>10.1007/s40262-022-01130-5</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/35641862/&quot;>https://pubmed.ncbi.nlm.nih.gov/35641862</a></p></li><li><p>Hirt, D, et al., &amp; Benaboud, S (2021). Population pharmacokinetics of intravenous and oral ciprofloxacin in children to optimize dosing regimens. <i>European journal of clinical pharmacology</i> 77(11) 1687–1695. DOI:<a href=&quot;https://doi.org/10.1007/s00228-021-03174-1&quot;>10.1007/s00228-021-03174-1</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/34160669/&quot;>https://pubmed.ncbi.nlm.nih.gov/34160669</a></p></li><li><p>Campoli-Richards, DM, et al., &amp; Ward, A (1988). Ciprofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. <i>Drugs</i> 35(4) 373–447. DOI:<a href=&quot;https://doi.org/10.2165/00003495-198835040-00003&quot;>10.2165/00003495-198835040-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3292209/&quot;>https://pubmed.ncbi.nlm.nih.gov/3292209</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end S01AE03;
